-
PDF
- Split View
-
Views
-
Cite
Cite
Corrigendum to: Treatment of Fabry Disease management with migalastat—outcome from a prospective 24 months observational multicenter study (FAMOUS), European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 2, March 2022, Page 211, https://doi.org/10.1093/ehjcvp/pvab073
- Share Icon Share
https://doi.org/10.1093/ehjcvp/pvab025
In the originally published version of this manuscript, there were two errors in the supplementary material. In Supplementary Table S2, the left ventricular mass index (LVMi) data for females and males were swapped. In Supplementary Table S7, there was an incorrect mutation which should be p.R118C instead of p.R1118C.
These errors have been corrected online.
© The Author(s) 2021. Published by Oxford University Press on behalf of The Royal Astronomical Society.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://dbpia.nl.go.kr/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
Issue Section:
Corrigendum